Chemoinformaics analysis of 2,6,6-TRIMETHYLCYCLOHEX-2-ENE-1-CARBALDEHYDE
Molecular Weight | 152.237 | nRot | 1 |
Heavy Atom Molecular Weight | 136.109 | nRig | 7 |
Exact Molecular Weight | 152.12 | nRing | 1 |
Solubility: LogS | -2.625 | nHRing | 0 |
Solubility: LogP | 2.832 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 28.1707 |
nHD | 0 | BPOL | 16.9193 |
QED | 0.417 |
Synth | 3.624 |
Natural Product Likeliness | 2.654 |
NR-PPAR-gamma | 0.777 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.003 |
Pgp-sub | 0.001 |
HIA | 0.006 |
CACO-2 | -4.379 |
MDCK | 0.000021 |
BBB | 0.907 |
PPB | 0.545678 |
VDSS | 3.551 |
FU | 0.429104 |
CYP1A2-inh | 0.063 |
CYP1A2-sub | 0.34 |
CYP2c19-inh | 0.045 |
CYP2c19-sub | 0.787 |
CYP2c9-inh | 0.031 |
CYP2c9-sub | 0.829 |
CYP2d6-inh | 0.013 |
CYP2d6-sub | 0.585 |
CYP3a4-inh | 0.057 |
CYP3a4-sub | 0.256 |
CL | 9.317 |
T12 | 0.344 |
hERG | 0.007 |
Ames | 0.023 |
ROA | 0.021 |
SkinSen | 0.93 |
Carcinogencity | 0.406 |
EI | 0.962 |
Respiratory | 0.836 |
NR-Aromatase | 0.047 |
Antiviral | No |
Prediction | 0.925663 |